AEON Biopharma AEON
NYSE AEON
$0.24 +0.01 (+4.75%)
As of: Oct 21, 2026 · 3:52 PM EDT

AEON Biopharma (AEON) Long-Term Debt Issuances (2021 - 2024)

Updated

AEON Biopharma's Long-Term Debt Issuances came in at $15 million for FY2024.

Analysis

AEON Biopharma (AEON) Long-Term Debt Issuances (2021 - 2024) Analysis & Trends

  • Long-Term Debt Issuances carries a three-year compound annual growth rate of 652.6% (FY2021 to FY2024).
  • The FY2024 figure represents the lowest annual Long-Term Debt Issuances since FY2021.
  • Per Business Quant, earlier years put Long-Term Debt Issuances at $44.5 million in FY2022 and $35,192 in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Issuance (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 8.94 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn -
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 1.98 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 AEON Biopharma 12.25 Mn -8.55 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2024 10.00 Mn
Mar 31, 2024 5.00 Mn
Mar 31, 2023 6.00 Mn
Dec 31, 2021 -3,495.00
Jun 30, 2021 -322.00
Mar 31, 2021 39,009.00
API Access

AEON Biopharma Long-Term Debt Issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-issuances&ticker=AEON&period=max&api_key=YOUR_API_KEY